Abalos Therapeutics GmbH

Manufacturer, Pharma, Essen, Germany

Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug ...

ActiTrexx GmbH

Manufacturer, Pharma, Mainz, Germany

Mission & Vision: ATreg – For a life without Transplant Rejection. Graft-versus-Host-Disease (GvHD) is a common complication of stem cell transplantation that is associated with high morbidity and mortality. Our goal is to prevent the development of GvHD at an early stage with the cellular ...

Algiax Pharmaceuticals GmbH

Manufacturer, Pharma, Erkrath, Germany

Cardior Pharmaceuticals GmbH

Manufacturer, Pharma, Hannover, Germany

Cardior Pharmaceuticals is an academic spin-off developing new therapeutics for the treatment and prevention of heart disease - the number one cause of death in the western world. Our lead development program is an oligonucleotide based inhibitor of a molecular master switch (microRNA) ...

CatalYm GmbH

Manufacturer, Pharma, Martinsried, Germany

CatalYm is a biopharmaceutical company developing novel cancer immunotherapies targeting Growth-and-Differentiation Factor 15 (GDF-15). Apart from its established role in cachexia, GDF-15 has been associated with immunosuppression in tissues and tumors and a rapidly growing body of literature ...

Eisbach Bio GmbH

Manufacturer, Pharma, Martinsried, Germany

Eisbach develops novel drugs that disrupt molecular machines essential to tumors with defined genetic vulnerabilities in the context of DNA damage and repair (DDR). Its proprietary platform creates targeted therapies that exploit disease-relevant vulnerabilities. By shutting off the machine’s ...

Exciva GmbH

Manufacturer, Pharma, Heidelberg, Germany

EXCIVA GmbH TARGETED DRUG RESCUE (TDR) There are about 3,000 drugs that have been approved by at least one country in this world. Just a handful of drugs received approval prior to the creation of the modern FDA in 1938, including Merck's morphine in 1827 and aspirin in 1899. FDA approved 1,453 ...

GeneQuine Biotherapeutics GmbH

Manufacturer, Pharma, Hamburg, Germany

MYR GmbH

Manufacturer, Pharma, Burgwedel, Germany

OMEICOS Therapeutics GmbH

Service, Pharma, Berlin, Germany

OMEICOS Therapeutics’ is focused on developing therapeutics that can be broadly deployed in inflammatory, cardiovascular, ophthalmology and other disease indications using its proprietary technology and extensive knowledge of omega-3 fatty acid metabolism and biology. Learn more Our pipeline of ...